Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have earned a consensus rating of “Hold” from the five brokerages that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have i
Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have earned a consensus rating of “Hold” from the five brokerages that are covering the firm, MarketBeat reports. One investment analyst … [+3321 chars]